Vesugen
Vesugen
Description
A vascular bioregulator peptide supporting blood vessel health and circulation. Important for cardiovascular longevity.
Overview
Vesugen (KED) was developed at the St. Petersburg Institute of Bioregulation and Gerontology by Khavinson and colleagues. It is studied for cardiovascular and immune support, with proposed effects on endothelial function and vascular gene regulation.
Mechanism of Action
Synthetic tripeptide (Lys-Glu-Asp / KED) proposed to bind regulatory DNA regions and modulate gene expression in vascular endothelial and immune tissues; classified as a Khavinson short-chain bioregulator.
Benefits
- •Vascular health
- •Blood flow
- •Circulation
- •Cardiovascular support
Reported Side Effects
- •Limited human safety data
- •Possible injection site reactions
Safety Notes
Limited independent clinical validation outside Russian literature. Research use only.
Scientific References
Related Bioregulator Peptides
Thymagen
Thymagen
An immune bioregulator peptide supporting thymus function and immune system health. Essential for immune longevity.
2 mgLivagen
Livagen
A liver bioregulator peptide supporting hepatic tissue regeneration and function. Essential for metabolic and detoxification health.
2 mgVesilute
Vesilute
A bioregulator peptide for bladder and prostate health. Supports urinary function and prostate tissue regeneration.
2 mgBronchogen
Bronchogen
A bioregulator peptide targeting lung and respiratory health. Supports bronchial tissue regeneration and respiratory function as part of longevity protocols.
2 mg